MP67. Tendyne System as Possibility to Solve Mitral Incompetence
Presented During: Moderated E-Posters
Nemocnice Ceske Budejovice
Ceske Budejovice, MD
Czech Republic - Contact Me
57 years, Cardiovascular surgeon. Focus arterial revascularisation, MIMVS, MIAVS, sutureless valves, catheter valves, reconstruction of the aortic valve, full thoracic and abdominal aorta, endovascular and hybride procedures too. Transapical aortic and mitral valve replacement plus surgical treatment of arterial fibrillation (thoracoscopic lone and concomitant procedures) is the bigest actual focus.
I am intrnational proctor for Perceval sutureless valve and for CoxMAZE procedures
Thursday, May 4, 2023: 6:30 PM - Saturday, May 6, 2023: 2:29 AM
New York Hilton Midtown
Room: Grand Ballroom Foyer
Description
Objective: We sould like to present our initial experiences with Tendyne system for mitral valve replacement as alternative for some patients who are not suitable candidate for standard surgery.
Metods: Between 9/21 and 1/22 we implanted in 7 patients with sever native mitral insufficiency Tendyne system. System was implanted via left aneteroalateral minithoracotomy in touch of optimal position for implantation. Av age 76,7 (70-85) year. 2 had previous CABG. Risk of periprocedural mortality (STS risk score) for standard mitral valve replacement was 9,8%. All patients had dominant pathology Carpentier I aetiology. All patients were evaluated by specialist from Abbott to confirm technical conditions and probablity of success.
Results: In all patients we system implanted succesfuly and without complications. No conversion or reoperning for bleeding. No wound infection, ICU stay av.2,4 (1-7 days), all stay av.12 (8-20 days). In all patients was mitral insufficiency changed from heavy lto zero. The same result (still zero) we see in early postprocerula follow.. MG on the prostehsis is low, 3,07 torr at discharge.
Conclusions: Tendyne system seems to be very effective catheter based metod of treatment of native mitral insufficiency. Seems to be an alternative in high risk patients. We need more patients and longer follow up for stronger conclusions.
Metods: Between 9/21 and 1/22 we implanted in 7 patients with sever native mitral insufficiency Tendyne system. System was implanted via left aneteroalateral minithoracotomy in touch of optimal position for implantation. Av age 76,7 (70-85) year. 2 had previous CABG. Risk of periprocedural mortality (STS risk score) for standard mitral valve replacement was 9,8%. All patients had dominant pathology Carpentier I aetiology. All patients were evaluated by specialist from Abbott to confirm technical conditions and probablity of success.
Results: In all patients we system implanted succesfuly and without complications. No conversion or reoperning for bleeding. No wound infection, ICU stay av.2,4 (1-7 days), all stay av.12 (8-20 days). In all patients was mitral insufficiency changed from heavy lto zero. The same result (still zero) we see in early postprocerula follow.. MG on the prostehsis is low, 3,07 torr at discharge.
Conclusions: Tendyne system seems to be very effective catheter based metod of treatment of native mitral insufficiency. Seems to be an alternative in high risk patients. We need more patients and longer follow up for stronger conclusions.